Clinical Trial Detail

NCT ID NCT03531632
Title MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors MacroGenics
Indications

colorectal cancer

Therapies

MGD007 + Retifanlimab

Age Groups: senior adult

No variant requirements are available.